Tilray Exports Medical Cannabis Products to New Zealand for Nationwide Distribution


Tilray, a global leader in medical cannabis research and production, today announced that Tilray medical cannabis products have been successfully exported to New Zealand and are now available for distribution nationwide. The products were produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada and can be dispensed to any patient with valid approval under New Zealand law.

“We are proud to offer New Zealand patients access to quality-controlled, pharmaceutical-grade medical cannabis products,” said Brendan Kennedy, Tilray President. “With Tilray products available in six countries representing four continents, we further our global mission of serving patients in need in a timeframe that matters.”

Tilray has signed an agreement with a leading New Zealand pharmaceutical distributor to supply pharmacies across the country with medical cannabis products. Products currently available in New Zealand include precisely formulated medical cannabis oils containing tetrahydrocannabinol (THC) and cannabidiol (CBD).